Literature DB >> 27822906

Simultaneous large bi-atrial device-related thrombi.

Jonas Dominik Häner1, Christian Seiler2.   

Abstract

Simultaneous appearance of a pacemaker-lead associated thrombus and a left atrial appendage closure device related thrombus in a patient with urothelial carcinoma shown in a transesophageal echocardiography.

Entities:  

Keywords:  Device-associated thrombus; Intra-cardiac thrombus; Left atrial appendage closure; Paraneoplastic hypercoagulability; Transesophageal echocardiography

Mesh：

Year:  2017        PMID： 27822906     DOI： 10.1007/s11239-016-1453-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


  6 in total

Review 1.  Treatment of Venous Thromboembolism With New Anticoagulant Agents.

Authors:  Cecilia Becattini; Giancarlo Agnelli
Journal:  J Am Coll Cardiol       Date:  2016-04-26       Impact factor: 24.094

Review 2.  Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis.

Authors:  Marc Carrier; Chris Cameron; Aurélien Delluc; Lana Castellucci; Alok A Khorana; Agnes Y Y Lee
Journal:  Thromb Res       Date:  2014-10-08       Impact factor: 3.944

Review 3.  International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  Dominique Farge; Henri Bounameaux; Benjamin Brenner; Francis Cajfinger; Philippe Debourdeau; Alok A Khorana; Ingrid Pabinger; Susan Solymoss; James Douketis; Ajay Kakkar
Journal:  Lancet Oncol       Date:  2016-10       Impact factor: 41.316

Review 4.  Epidemiology of cancer-related venous thromboembolism.

Authors:  Ted Wun; Richard H White
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

Review 5.  Guidance for the prevention and treatment of cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Marc Carrier; David A Garcia; Agnes Y Y Lee
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

6.  Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.

Authors:  Simon Mantha; Eva Laube; Yimei Miao; Debra M Sarasohn; Rekha Parameswaran; Samantha Stefanik; Gagandeep Brar; Patrick Samedy; Jonathan Wills; Stephen Harnicar; Gerald A Soff
Journal:  J Thromb Thrombolysis       Date:  2017-02       Impact factor: 2.300
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.